Robert Stockton Jones Jr.

Array ( [id] => 17387056 [patent_doc_number] => 20220034908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FABRY DISEASE, CONTAINING TSP1 PROTEIN INHIBITOR AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 17/280567 [patent_app_country] => US [patent_app_date] => 2019-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12456 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17140093 [patent_doc_number] => 20210308104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG OLAMINE [patent_app_type] => utility [patent_app_number] => 17/263856 [patent_app_country] => US [patent_app_date] => 2019-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2883 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17109937 [patent_doc_number] => 20210290534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => METHOD FOR THE PRODUCTION OF FREEZE-DRIED PELLETS COMPRISING AN ANTI-COAGULATION FACTOR XIa (FXIa) ANTIBODY [patent_app_type] => utility [patent_app_number] => 17/257827 [patent_app_country] => US [patent_app_date] => 2019-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7636 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16961683 [patent_doc_number] => 20210213182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => MEDICAL HYDROGEL HAVING RADIATION PROTECTION FUNCTION [patent_app_type] => utility [patent_app_number] => 17/274134 [patent_app_country] => US [patent_app_date] => 2019-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3279 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12183932 [patent_doc_number] => 20180042868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'TAMPER RESISTANT FORMULATION OF EPHEDRINE AND ITS DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 15/674613 [patent_app_country] => US [patent_app_date] => 2017-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19757 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12029734 [patent_doc_number] => 20170319833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'INTRAVAGINAL DRUG DELIVERY DEVICE' [patent_app_type] => utility [patent_app_number] => 15/431005 [patent_app_country] => US [patent_app_date] => 2017-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7449 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15431005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10481781 [patent_doc_number] => 20150366798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'PHARMACEUTICAL ADHESIVE COMPOSITIONS FOR TREATMENT OF EPISTAXIS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/702376 [patent_app_country] => US [patent_app_date] => 2015-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16923 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14702376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754764 [patent_doc_number] => 20120027827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Method and Composition for Reducing Exhaled Carbon Dioxide Emissions' [patent_app_type] => utility [patent_app_number] => 13/192163 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3600 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027827.pdf [firstpage_image] =>[orig_patent_app_number] => 13192163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818641 [patent_doc_number] => 20120065261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Creatine compositions for skin treatment' [patent_app_type] => utility [patent_app_number] => 13/066291 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14877 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065261.pdf [firstpage_image] =>[orig_patent_app_number] => 13066291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110408 [patent_doc_number] => 20110189269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Extended release composition containing tramadol' [patent_app_type] => utility [patent_app_number] => 12/926463 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6524 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189269.pdf [firstpage_image] =>[orig_patent_app_number] => 12926463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669121 [patent_doc_number] => 20110318390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Bioactive Dose Having a Rapid Release Coating or Rapid Release Layer Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder Absorption of a Bioactive' [patent_app_type] => utility [patent_app_number] => 12/824803 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6270 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12824803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221871 [patent_doc_number] => 20120136071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'Medicinal Cream For Diaper Rash And A Process To Make It' [patent_app_type] => utility [patent_app_number] => 13/257978 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7476 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 42953 [patent_doc_number] => 07781472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'Therapy for the treatment of disease' [patent_app_type] => utility [patent_app_number] => 12/710310 [patent_app_country] => US [patent_app_date] => 2010-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11603 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/781/07781472.pdf [firstpage_image] =>[orig_patent_app_number] => 12710310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710403 [patent_doc_number] => 20120003309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Solid Dosage Forms Of Bendamustine' [patent_app_type] => utility [patent_app_number] => 13/132343 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20465 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603789 [patent_doc_number] => 20100063029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'USE OF S-10-HYDROXY-10,11-DIHYDRO-CARBAMAZEPINE FOR THE TREATMENT OF ANXIETY AND BIPOLAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/616192 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3089 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063029.pdf [firstpage_image] =>[orig_patent_app_number] => 12616192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6455408 [patent_doc_number] => 20100189785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Use of D-ribose for fatigued subjects' [patent_app_type] => utility [patent_app_number] => 12/583430 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3367 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189785.pdf [firstpage_image] =>[orig_patent_app_number] => 12583430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6342934 [patent_doc_number] => 20100330014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'COMPOSITION FOR EXTERNAL APPLICATION ON SKIN, AND SKIN-WHITENING COSMETIC' [patent_app_type] => utility [patent_app_number] => 12/865494 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4227 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330014.pdf [firstpage_image] =>[orig_patent_app_number] => 12865494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617203 [patent_doc_number] => 20100310652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'COATED EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF LEVETIRACETAM' [patent_app_type] => utility [patent_app_number] => 12/809164 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2435 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310652.pdf [firstpage_image] =>[orig_patent_app_number] => 12809164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546811 [patent_doc_number] => 20090156688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'SUPPRESSANT OF TOXICITY INDUCED BY CANCER CHEMOTHERAPEUTIC AGENT AND COMPOSITION OF CANCER CHEMOTHERAPEUTIC AGENT CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/338912 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5974 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156688.pdf [firstpage_image] =>[orig_patent_app_number] => 12338912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291046 [patent_doc_number] => 20090023776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'FARNESYL PROTEIN TRANSFERASE INHIBITOR COMBINATIONS WITH ANTIESTROGEN AGENTS' [patent_app_type] => utility [patent_app_number] => 12/240075 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11106 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023776.pdf [firstpage_image] =>[orig_patent_app_number] => 12240075 [rel_patent_id] =>[rel_patent_doc_number] =>)